Background Initial randomised controlled trials (RCTs) showed that prophylactic
azithromycin in pregnant women improved maternal and neonatal outcomes; however, the …

To determine whether gestational use of all or specific macrolides (azithromycin,
clarithromycin, roxithromycin or erythromycin) lead to an increase in rates of overall major …

Importance Bacterial vaginosis (BV) is a well-known risk factor for preterm birth. Molecular
diagnosis of BV is now available. Its impact in the screening and treatment of BV during …

Introduction In high mortality settings, prophylactic azithromycin has been shown to improve
birth weight and gestational age at birth when administered antenatally, to reduce the …

Introduction Maternal and neonatal infections are among the most frequent causes of
maternal and neonatal mortality, and current antibiotic strategies have been ineffective in …

Objective This systematic review and meta-analysis investigated whether the use of
azithromycin during labour or caesarean section reduces the incidence of sepsis and …

Introduction In high mortality settings, prophylactic azithromycin has been shown to improve
birth weight and gestational age at birth when administered antenatally, to reduce the …

Introduction Infections are a leading cause of neonatal mortality globally and can be
transmitted from mother-to-child vertically or horizontally. Fiji has higher rates of serious …

Background Trials evaluating antimalarials for intermittent preventive treatment in pregnancy
(IPTp) have shown that dihydroartemisinin-piperaquine (DP) is a more efficacious …

Introduction Infections are a leading cause of neonatal mortality globally and can be
transmitted from motherto-child vertically or horizontally. Fiji has higher rates of serious …